Stereotactic body radiotherapy (SBRT) is a technologically sophisticated form of
radiotherapy that holds significant potential to effectively treat high-risk prostate cancer …

Simple Summary Stereotactic body radiotherapy, ie, high-precision radiotherapy delivering
high doses within a few treatment sessions, is a very convenient treatment option, which has …

Purpose To explore the efficacy and toxicity of stereotactic body radiation therapy (SBRT) in
high-risk prostate cancer (HRPCa) in a consortium of 7 institutional phase 2 trials and …

Simple Summary Prostate cancer (PCa) is the most diagnosed malignancy of men
worldwide, and radiotherapy (RT) is a main treatment option for patients in all disease …

Background Large variation regarding prescription and dose inhomogeneity exists in
stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer. The …

Purpose Ultrahypofractionation is appealing for prostate cancer (PCa) due to low α/β, and
increasing the dose per fraction could improve the therapeutic index. Here we report the …

Prostate cancer is the most commonly diagnosed cancer among men around the world.
Radiotherapy is a standard of care treatment option for men with localized prostate cancer …

Objectives: To report feasibility, early toxicity, and PSA kinetics following gantry-based,
stereotactic radiotherapy (SBRT) boost within a prospective, phase 2, multicenter study …

Purpose Dose-escalated stereotactic ablative radiotherapy (SABR) to the whole prostate
may be associated with better outcomes but has a risk of increased toxicity. An alternative …

Simple Summary Magnetic resonance (MR)-guided stereotactic body radiotherapy
(MRgSBRT) with concomitant whole-pelvic nodal radiotherapy (WPRT) represents a novel …